While noting that further measures to revive the exchange have yet to be announced, Citi analyst Tan Yong Hong in a Feb 13 ...
The benchmark indices ended the day sharply lower, with the Nifty slipping below the 23,000 mark and the Sensex dropping ...
NATCO Pharma stock has declined 34% over six days due to disappointing Q3 FY25 results, including a 37.4% revenue drop and a ...
Indian IT exporter Hexaware Technologies' HEXW.NS $1 billion initial public offering was fully subscribed in the final hours of the share sale on Friday, driven largely by institutional buyers as ...
More broadly, Wall Street is thinking along the same lines. Palantir's median target price of $96 per share implies 18% ...
India Today on MSN23h
Not Trump's tariffs, but this is what's making stock market investors anxiousThe stock market jitters have occurred despite government measures, including tax relief and the Reserve Bank of India's (RBI ...
MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...
According to experts, Donald Trump's tariff policy, weakness in INR, average Q3FY25 results season, sluggish economic growth, ...
The Indian stock market faces uncertainty due to trade wars and capital outflows, yet experts believe it may be close to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback